← Open Payments lookup

SOE-MOE KYAW: Open Payments

NPI 1871534461 · UPLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$824 in 21 payments from 10 companies in 2025. Trend: 2023 $608 · 2024 $469 · 2025 $824

Food & beverage: $824
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc2$252
E.R. Squibb & Sons, L.L.C.3$179
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$122
Axsome Therapeutics, Inc.5$108
Takeda Pharmaceuticals U.S.A., Inc.2$42
Neurocrine BioSciences, Inc.1$33
Alkermes, Inc.1$29
Corium, LLC1$21
ABBVIE INC.1$20
Supernus Pharmaceuticals, Inc.1$17

Products named: INVEGA SUSTENNA, COBENFY, CAPLYTA, Auvelity, TRINTELLIX, INGREZZA, VIVITROL, Azstarys.

Industry payments across CA — which companies pay providers there.